{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:20:57Z","timestamp":1791901257946,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015916","name":"Fujian Province Key Laboratory of Special Aquatic Formula Feed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015916","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115649","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:24:19Z","timestamp":1760804659000},"page":"115649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Exploring the role of OSMR in gastric cancer: from oncogenic functions to relevant immune features"],"prefix":"10.1016","volume":"167","author":[{"given":"Yanqin","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangchi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongta","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2025.115649_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.intimp.2025.115649_bb0010","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2025.115649_bb0015","first-page":"1","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2025.115649_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10254-003-0013-1","article-title":"Oncostatin M, a multifunctional cytokine","volume":"149","author":"Tanaka","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.intimp.2025.115649_bb0025","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-21-0483","article-title":"Oncostatin M receptor-targeted antibodies suppress STAT3 signaling and inhibit ovarian Cancer growth","volume":"81","author":"Geethadevi","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115649_bb0030","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nn.4295","article-title":"Control of glioblastoma tumorigenesis by feed-forward cytokine signaling","volume":"19","author":"Jahani-Asl","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115649_bb0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/ERC-11-0326","article-title":"Oncostatin M suppresses oestrogen receptor-\u03b1 expression and is associated with poor outcome in human breast cancer","volume":"19","author":"West","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.115649_bb0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/path.4305","article-title":"Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma","volume":"232","author":"Caffarel","year":"2014","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115649_bb0045","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10120-019-00934-y","article-title":"Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M","volume":"22","author":"Yu","year":"2019","journal-title":"Gastric Cancer: Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc."},{"issue":"1","key":"10.1016\/j.intimp.2025.115649_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3892\/or.2015.3951","article-title":"Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis","volume":"34","author":"Zhu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.115649_bb0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bjc.2016.199","article-title":"Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival","volume":"115","author":"Kucia-Tran","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.115649_bb0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1541-7786.MCR-16-0337","article-title":"Potent EMT and CSC phenotypes are induced by Oncostatin-M in pancreatic Cancer","volume":"15","author":"Smigiel","year":"2017","journal-title":"Mol. Cancer Res.: MCR"},{"key":"10.1016\/j.intimp.2025.115649_bb0065","doi-asserted-by":"crossref","unstructured":"S. Vollmer, V. Kappler, J. Kaczor, D. Fl\u00fcgel, C. Rolvering, N. Kato, T. Kietzmann, I. Behrmann, C. Haan, 1Hypoxia-inducible factor 1alpha is up-regulated by oncostatin M and participates in oncostatin M signaling, Hepatology (Baltimore, Md.) 50(1) (2009) 253\u201360.","DOI":"10.1002\/hep.22928"},{"issue":"10","key":"10.1016\/j.intimp.2025.115649_bb0070","first-page":"1296","article-title":"STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells, FASEB journal\u202f: official publication of the Federation of American Societies for","volume":"19","author":"Jung","year":"2005","journal-title":"Exp. Biol."},{"issue":"13","key":"10.1016\/j.intimp.2025.115649_bb0075","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/onc.2013.115","article-title":"STAT3 and HIF1\u03b1 cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells","volume":"33","author":"Pawlus","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2025.115649_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.115649_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2016.03.012","article-title":"High co-expression of PD-L1 and HIF-1\u03b1 correlates with tumour necrosis in pulmonary pleomorphic carcinoma","volume":"60","author":"Chang","year":"2016","journal-title":"Eur. J. Cancer (Oxford, England): 1990"},{"issue":"3","key":"10.1016\/j.intimp.2025.115649_bb0090","first-page":"999","article-title":"High PD-L1 expression drives glycolysis via an Akt\/mTOR\/HIF-1\u03b1 axis in acute myeloid leukemia","volume":"43","author":"Ma","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2025.115649_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886931","article-title":"Burgeoning exploration of the role of natural killer cells in anti-PD-1\/PD-L1 therapy","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115649_bb0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","article-title":"Oncostatin M and interleukin-31: cytokines, receptors, signal transduction and physiology","volume":"26","author":"Hermanns","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"52","key":"10.1016\/j.intimp.2025.115649_bb0105","doi-asserted-by":"crossref","first-page":"40742","DOI":"10.1074\/jbc.M005408200","article-title":"Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptor","volume":"275","author":"Hermanns","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.115649_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.5010","article-title":"Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma","volume":"244","author":"Kucia-Tran","year":"2018","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115649_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8010008","article-title":"Cancer stem cell plasticity drives therapeutic resistance","volume":"8","author":"Doherty","year":"2016","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.intimp.2025.115649_bb0120","doi-asserted-by":"crossref","first-page":"965","DOI":"10.7150\/jca.51079","article-title":"Infiltrating immune cells in gastric Cancer: a novel predicting model for prognosis","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2025.115649_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148667","article-title":"Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment","volume":"132","author":"Araujo","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2025.115649_bb0130","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/s41467-021-27607-8","article-title":"Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115649_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijrobp.2023.07.033","article-title":"Oncostatin M\/Oncostatin M receptor signal induces radiation-induced heart fibrosis by regulating SMAD4 in fibroblast","volume":"118","author":"Xu","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.intimp.2025.115649_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41232-024-00347-0","article-title":"Oncostatin M-driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis","volume":"44","author":"Huynh","year":"2024","journal-title":"Inflamm. Regen."},{"issue":"1","key":"10.1016\/j.intimp.2025.115649_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.5871","article-title":"Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis","volume":"257","author":"Di Maira","year":"2022","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115649_bb0150","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1097\/JS9.0000000000001479","article-title":"Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study","volume":"110","author":"Guo","year":"2024","journal-title":"Int. J. Surg. (London, England)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115649_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70602","article-title":"A mitochondria-related signature in diffuse large B-cell lymphoma: prognosis, immune and therapeutic features","volume":"14","author":"Zhou","year":"2025","journal-title":"Cancer Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:28:30Z","timestamp":1765456110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925016406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S1567576925016406"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115649","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of OSMR in gastric cancer: from oncogenic functions to relevant immune features","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115649"}}